| |
|
|
|
Antares Pharma Inc.  
|
|
3.26 -0.05 (-0.02%) |
03-22 10:31 |
|
Open: |
3.29 |
Pre close: |
3.31 |
Target:
|
4.25 
|
|
High: |
3.34 |
Low: |
3.21 |
Resistance:
|
3.64
3.96
|
|
Volume: |
355,226 |
Market Cap: |
523M |
Support:
|
3.11
2.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.38
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
3.59 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
3.24 |
Stochastic Oscillator |
%K(14,3):
|
14.70 |
|
MA(250): |
3.01 |
%D(3): |
20.73 |
|
Average Volume(K) |
3-Month: |
96792
|
52-Week |
High:
|
3.96 |
|
10-Days: |
120547 |
Low: |
1.99 |
|
RSI |
RSI(14):
|
43.01 |
Change(%): |
50.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.040 |
Return on Equity (ttm) |
-18.0 |
Shares Out. (M) |
160.53 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-8.0 |
Shares Float (M) |
144.78 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.76 |
% Held by Insiders |
10.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
34.1 |
% Held by Institutions |
57.50 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
14.860 |
EBITDA (p.s.) |
0.000 |
P/E |
-82.55 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.22 |
|
Profit Margin |
-13.13 |
Operating Cash Flow
(M) |
-17.32 |
P/S |
1325134976.00 |
|
Operating Margin |
-26.12 |
Levered Free Cash Flow
(M) |
-16.31 |
P/CF |
-30.60 |
|
|
|
|
|
|
